NeelAgil Technologies

Hyderabad, India Founded: 2018 • Age: 8 yrs
Developer of oral insulin protein-based therapeutics for treating type 1 diabetes
Annual revenue $2,689 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About NeelAgil Technologies

NeelAgil Technologies is a company based in Hyderabad (India) founded in 2018 by Neelam Vishwanath Dwivedi and Arunagirinathan M Adhimoolam. NeelAgil Technologies operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.

  • Headquarter Hyderabad, India
  • Founders Neelam Vishwanath Dwivedi, Arunagirinathan M Adhimoolam
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Neelagil Technologies Private Limited
  • Date of Incorporation 11 Dec, 2017
  • Jurisdiction Thane, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.69 K (USD)
    0
    as on Mar 31, 2021
  • Net Profit
    -$4.63 K (USD)
    63.19
    as on Mar 31, 2021
  • EBITDA
    -$7.32 K (USD)
    41.78
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NeelAgil Technologies

Premium access

Detailed funding history for NeelAgil Technologies

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NeelAgil Technologies

Investments
Premium access

Investment portfolio details for NeelAgil Technologies

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NeelAgil Technologies

Premium access

Detailed financials for NeelAgil Technologies

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Neelagil Technologies Comparisons

NeelAgil Technologies Primary company
Description
Developer of oral insulin protein-based therapeutics for tre...
Location
Hyderabad, India
Founded Year
2018
Annual Revenue
$2.69 K (USD)
Net Profit
-$4.63 K (USD)
EBITDA
-$7.32 K (USD)
Employees
Not available
Premium access

Peer comparison for NeelAgil Technologies

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NeelAgil Technologies

NeelAgil Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genetically engineered cell therapies are developed for multiple disorders.
Locked Locked Locked
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
Locked Locked Locked
Therapeutics for diabetes and obesity treatment are developed.
Locked Locked Locked
Therapies for metabolic and orphan diseases are developed by Rezolute.
Locked Locked Locked
Developer of autologous cell therapies
Locked Locked Locked
Innovates long-acting oral therapies to simplify patient medication regimens.
Premium access

Detailed competitors of NeelAgil Technologies

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Neelagil Technologies

Premium access

Complete news archive for NeelAgil Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NeelAgil Technologies

NeelAgil Technologies was founded in 2018.

NeelAgil Technologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Neelam Vishwanath Dwivedi is the current CEO of NeelAgil Technologies. They have also founded this company.

Annual revenue of NeelAgil Technologies is $2.69K as on Mar 31, 2021.

NeelAgil Technologies was founded in 2018 in Hyderabad, India, within the biotechnology sector. Oral insulin protein-based therapeutics are developed for type 1 diabetes treatment. Nanotechnology-based encapsulation technology is provided to protect insulin from gastric pH and enzymatic degradation. This approach is targeted at insulin-dependent patients, with operations focused on advancing delivery methods for diabetes management.

NeelAgil Technologies's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available